& ldquo;、Public hospital cancel drug bonus、Strictly control the impact of the growth of drug costs，Pharmaceutical terminal sales have slowed down year by year。& rdquo; November 23，CFDA Director Lin Jianning of the Institute My stake betting appof stake online sports bettingMedical Economics of the Southern Medical Economics of Southern Medical Economics at the 28th National Medical Economic Information Conference & RDQUO; Introduction，The drug market sales in the first three quarters of this year were 1128 billion yuan，The year -on -year growth rate decreased from 11%last year to 7.9%。

 

  Where，Hospital market drug sales 773.8 billion yuan，increased by 7.6%year -on -year; the retail market drug sales were 252.5 billion yuan，increased by 8.5%year -on -year; grassroots medical care 102.7 billion yuan，rose 13.2%; Sanda terminal divided into 68.6%of the pharmaceutical market in the first three quarters、22.3%and 9.1%。

 

  In addition，Pharmaceutical exports continue to slug。In the first three quarters of this year，my country's pharmaceutical products export value 41.36 billion US dollars，decreased by 2.0%year -on -year，For a new low for the past 10 years。Last year，my country's medical export annual increased by 2.7%。but，The growth rate of sales revenue in the pharmaceutical industry is slowly recovered。

 

  According to the data released by the Institute Stake Sports Bettingstake online sports bettingof Medical Economics, the Institute of Medical Economics, it shows，From January to April this year, the sales revenue of the pharmaceutical industry increased by 10.4%，increased by 10.2%in the first half of the year; the sales revenue of the pharmaceutical industry in the first three quarters was 2091 billion yuan，increase 10.1%，Forecast annual sales growth will be faster than 2015。

 

   & ldquo; This year's pharmaceutical industry output value growth has stopped falling and stabilizing，Profit growth rate increases。& rdquo; Lin Jianning emphasized，Although there are signs of recovery in the pharmaceutical industry，But not blindly optimistic，& ldquo; Because the terminal growth is not ideal，A negative growth in the export of medicine，The operating trend of the industry still needs to be observed。& rdquo;

 

  Lin Jianning expects，2017 China's pharmaceutical industry sales revenue is expected to increase 13%year -on -year，But the growth rate of sales of the pharmaceutical terminal market is declining significantly，Only 7.6%。In his opinion，These two key economic data appear stake sports betting app& ldquo;，A series of new My stake betting appproblems and contradictions facing the pharmaceutical economy are not related，& ldquo; These appearances are speed problems，But in essence, the problem of supply structure。The key to the development of the pharmaceutical industry in the future is to rely on innovation to lead。& rdquo; Lin Jianning said to the 21st Century Business Herald。

 

  Facing the complex situation of the domestic pharmaceutical economy，How to choose the path of innovation in the pharmaceutical industry? Tao Jianhong, Deputy Director of CFDA Southern Medical Economics Institute, suggests，In the uncertain R & D and innovation，Should be used for international cooperation，Realize the global allocation of resources，Make the R & D unit more flexible and executive，Create a new R & D model of VC (venture capital)+IP (intellectual property)+CRO。